Tibolone

Anti-TIGAR TP53 induced glycolysis regulatory phosphatase, 2

L-N-Butylsulfonyl-p-hydroxyphenylalanine is an intermediate in the synthesis of Tirofiban-d6, the labeled analogue of Tirofiban, a specific nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist.

L-N-Butylsulfonyl-p-hydroxyphenylalanine is an intermediate in the synthesis of Tirofiban-d6, the labeled analogue of Tirofiban, a specific nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist.

L-N-Butylsulfonyl-p-hydroxyphenylalanine is an intermediate in the synthesis of Tirofiban-d6, the labeled analogue of Tirofiban, a specific nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist.

L-N-Butylsulfonyl-p-hydroxyphenylalanine is an intermediate in the synthesis of Tirofiban-d6, the labeled analogue of Tirofiban, a specific nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

Tibolone is an estrogen-like compound used for the treatment of the symptoms associated with menopausal transition (i.e.

Tibolone is an estrogen-like compound used for the treatment of the symptoms associated with menopausal transition (i.e.

Tibolone is an estrogen-like compound used for the treatment of the symptoms associated with menopausal transition (i.e.